On November 11, as of the close of Hong Kong stocks, the Hang Seng Index fell 1.45%to 20426.93 points.Ziyuanyuan (08223.HK) closed at HK $ 2.04/share, an increase of 0.49%, the turnover of 56,000 shares, the turnover of HK $ 110,700, and an amplitude of 11.33%.
In the past month, Ziyuanyuan has fallen 13.25%, this year, a cumulative increase of 24.4%, and the end of 21.59%of the Hang Seng Index.
Financial data shows that as of June 30, 2024, Ziyuanyuan achieved total operating income of 187 million yuan, an increase of 6.66%year -on -year; net profit attributable to mother1.19%; gross profit margin 24.86%, asset -liability ratio 44.89%.
In terms of institutional rating, there is currently no recommendation on investment rating suggestions for the stock.
In terms of industry valuation, the average value -in -earnings ratio (TTM) of medical care equipment and service industry is 32.61 times, and the industry is 5.29 times.Ziyuanyuans price -earnings ratio is 54.36 times, and the industry ranks 46th; other superstar Medical Holdings (02393.HK) is 0.14 times, Yongsheng Medical (01612.HK) is 4.14 times, Global Medical (02666.HK) is 4.19 times, and the new is new.Century Medical (01518.HK) was 4.78 times, and Ruici Medical (01526.HK) was 5.29 times.
Data show that Ziyuanyuan Holding Group Co., Ltd., the Hong Kong Joint Exchange Listing Enterprise (stock code: 08223.HK), is headquartered in Shenzhen, China, in Beijing, Hangzhou, and in Hangzhou, Hangzhou, Hangzhou, and in Hangzhou, Hangzhou, Hangzhou, and in Hangzhou, and in Hangzhou, in Hangzhou, Hangzhou, Hangzhou, Hangzhou, Hangzhou, and Hangzhou, and Hangzhou, respectivelyWuhan, Henan, Chengdu, Guangzhou, Hong Kong and other places have offices.
Provide comprehensive services for medical institutions, patients, and medical enterprises, and establishes its own brand influence in the consumer medical field such as oral, medical beauty, and confinement center.The layout of the medical and health industry chain of medical services, medical device research and development, production and sales, medical smart supply chain, and SPD services, through digital intelligent technology capabilities, to play the overall role of the industry chain, and won the recognition of high -tech enterprises.It has become a technology -driven full -link medical industry comprehensive service provider.
(The above content is a public message based on the financial community and is intelligently generated by the program or algorithm.This article comes from: the financial industry
Author: market
- viewpoint->
